Since the discovery of the CFTR gene in 1989, more than 1900 mutations and variants have been described. Many of these mutations are âprivateâ, having been described only in one patient and/or family. Routine testing for all possible mutations is neither feasible nor cost effective and is therefore confined to testing for the most common mutations.
CF-EU2v1 is the only commercially available pan-European cystic fibrosis testing kit designed specifically to address the most common mutations found across populations of European origin. The assay identifies 50 mutations in total and also analyses the intron 8 polyT tract with accurate measurement of the adjacent TG repeat.
Instructions for use
KIT, Eluci, CFEU2v1, 50 T, IVD-CE
2 PCR tubes per sample, 50 mutations detected, Genetic Analyzer platform
Safety data sheet
Guide to analysis
Guide To Interpretation